ANTI-EPILEPTIC DRUGS FOR PEDIATRICS MARKET ANALYSIS

Anti-Epileptic Drugs for Pediatrics Market, By Drug Type (First generation anti-epileptic drugs, Second generation anti-epileptic drugs, Third generation anti-epileptic drugs), By Route of Administration (Oral, Injectable, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)

Published In : Jan 2024
Code : CMI823
Pages :190
Formats :
Excel and PDF
Industry : Pharmaceutical

Anti-Epileptic Drugs for Pediatrics MarketSize and Trends

The global anti-epileptic drugs for pediatrics market size is expected to reach US$ 2,034.7 Mn by 2030, from US$ 1,202.4 Mn in 2023, exhibiting a compound annual growth rate (CAGR) of 7.8% during the forecast period.

Global Anti-epileptic Drugs For Pediatrics Market Trends

Increasing investments by key market players

Increasing adoption of inorganic growth strategies, such as investments, is expected to drive the global anti-epileptic drugs for pediatrics market over the forecast period.

For instance, in March 2022, Aculys Pharma, Inc., a pharmaceutical company, announced that it has raised a total of US$ 24 million in Series B Round with the participation by JIC Venture Growth Investments, Mitsubishi UFJ Capital, and Spiral Capital as new investors. The funding helps for clinical development and commercial activities for launching research and development activities of epileptic seizure emergencies

Figure 2. Global Anti-epileptic Drugs for Pediatrics Market Share (%), by Drug Type, 2023